饮食摄入量和结果:从-HF进行的二次分析
Clara Saldarriaga1, Eloisa Colin-Ramirez2, Sunjidatul Islam3
1Centro Cardiovascular Colombiano Clinica Santa Maria (Clinica Cardio VID), Antioquia, Colombia.
Journal of cardiac failure
|July 6, 2024
概括
饮食中的摄入量与24个月内心力衰竭 (HF) 患者的临床结果无关. 然而,达到每天低于1500毫克的摄入量显示出潜在的益处,需要进一步研究.
科学领域:
- 心脏病学 心脏病学
- 营养科学 营养科学
- 临床研究 临床研究
背景情况:
- 饮食中的限制是心力衰竭 (HF) 患者的常见建议.
- 以前的随机临床试验没有证明限制对高血压的临床结果有显著的益处.
研究的目的:
- 评估基线饮食摄入量及其6个月后变化与12个月和24个月后临床结果之间的关联.
- 评估与摄入有关的心血管住院,急诊室访问和全因死亡.
主要方法:
- 对SODIUM-HF试验数据进行了后期分析.
- 使用多变量Cox比例危险回归模型来分析摄入量与终点之间的关联.
- 参与者的饮食摄入量在随机化和6个月后被测量.
主要成果:
- 在基线摄入量或其6个月变化和12个月或24个月的结果之间没有发现任何关联.
- 与较高的基线摄入量相关的因素包括更高的卡路里消耗,更高的BMI和从加拿大的招聘.
- 响应者分析表明,对于那些在6个月内每天摄入量<1500毫克的人来说,12个月后复合结果和心血管住院的风险可能会降低.
结论:
- 饮食中的摄入量与心力衰竭患者24个月以上的临床结果无关.
- 响应者分析表明,达到的目标降低水平 (<1500毫克/天) 可能需要进一步调查潜在的益处.
- 需要进行进一步的研究,以探索减少在成功达到较低摄入量水平的特定患者亚组中的影响.
相关概念视频
Antihypertensive Drugs: Potassium-Sparing Diuretics
511
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
511
Heart Failure Drugs: Diuretics
362
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
362
Hypertension and Regulation of Blood Pressure
2.0K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.0K
Regulation of Sodium and Potassium
478
The regulation of sodium and potassium ion concentrations in the human body is a complex process governed primarily by hormones such as aldosterone, antidiuretic hormone (ADH), and atrial natriuretic peptide (ANP).
Sodium Regulation
Sodium ions make up approximately 90% of extracellular cations, with a normal blood plasma concentration of 136–148 mEq/L. A decrease in blood volume and pressure triggers the release of renin from granular cells in the juxtaglomerular complex (JGC), primarily...
Sodium Regulation
Sodium ions make up approximately 90% of extracellular cations, with a normal blood plasma concentration of 136–148 mEq/L. A decrease in blood volume and pressure triggers the release of renin from granular cells in the juxtaglomerular complex (JGC), primarily...
478
Alterations in Blood Pressure
1.2K
Alterations in blood pressure, such as hypertension (high blood pressure) and hypotension (low blood pressure), significantly affect human health. Understanding these conditions' classifications, causes, and symptoms is essential for effective management and treatment.
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart...
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart...
1.2K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
419
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
419


